Atlas Trials

Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics

Clinical trial NCT04870411 · TERMINATED

Trial details

NCT number
NCT04870411
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
TERMINATED
Study type
OBSERVATIONAL
Autoimmune DiseasesInflammatory Disorder
Start date
2021-05-12
Primary completion
2021-08-31
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.